Ignite Creation Date:
2025-12-25 @ 3:23 AM
Ignite Modification Date:
2026-03-06 @ 6:14 PM
Study NCT ID:
NCT02511405
Status:
COMPLETED
Last Update Posted:
2018-10-23
First Post:
2015-07-29
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase 3, Pivotal Trial of VB-111 Plus Bevacizumab vs. Bevacizumab in Patients With Recurrent Glioblastoma (GLOBE)
Sponsor:
Vascular Biogenics Ltd. operating as VBL Therapeutics
Organization: